Amneal Pharmaceuticals, Inc. AMRX Specialty — Cost of Goods Sold

Similar metrics at other companies

PFG

PFGCSpecialty — Cost of Goods Sold

$984M+5.8%

LKQSpecialty — Cost of goods sold

$310M+3.7%

RPMSpecialty Products Group — Cost of Goods Sold

$109.62M-2.7%

HSICGlobal Specialty Products — Cost of Goods Sold

$177M+9.9%

BCPCSpecialty Products — Cost of Sales

$14.26M-10.8%

PRMSpecialty Products — Adjusted cost of goods sold

$45.29M+100%

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold?

Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — cost of goods sold of $61.48M in Q4 2025.

How has Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold changed year-over-year?

Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold increased by 21.2% year-over-year, from $50.71M to $61.48M.

What is the long-term trend for Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold?

Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold has grown at a 6.2% compound annual growth rate (CAGR), from $193.56M to $245.92M.

What does specialty — cost of goods sold mean?

Includes all direct costs associated with the manufacturing, procurement, and distribution of specialty pharmaceutical products. This metric is a critical component in determining the segment's gross margin and overall production efficiency. Monitoring this helps identify trends in supply chain costs, raw material pricing, and manufacturing scalability.